These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3297282)

  • 21. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
    Bompard Y; Lambert T; Gantzer A; Chastel A; Voinnesson A; Aufrant C
    Pathol Biol (Paris); 1988 May; 36(5):521-4. PubMed ID: 3043351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem/cilastatin in the treatment of obstetric and gynecologic infections: a review of worldwide experience.
    Sweet RL
    Rev Infect Dis; 1985; 7 Suppl 3():S522-7. PubMed ID: 3901216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imipenem/cilastatin in the treatment of obstetric and gynecologic infections.
    Berkeley AS; Freedman K; Hirsch J; Ledger WJ
    Am J Med; 1985 Jun; 78(6A):79-84. PubMed ID: 3859219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with imipenem/cilastatin: analysis of a multicenter study.
    Shah PM
    Rev Infect Dis; 1985; 7 Suppl 3():S471-5. PubMed ID: 3901210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience.
    Acar JF
    Rev Infect Dis; 1985; 7 Suppl 3():S513-7. PubMed ID: 3931199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
    Wang C; Calandra GB; Aziz MA; Brown KR
    Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
    Raad II; Abi-Said D; Rolston KV; Karl CL; Bodey GP
    Cancer; 1998 Jun; 82(12):2449-58. PubMed ID: 9635539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
    Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
    Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of imipenem/cilastatin sodium in children].
    Meguro H; Arimasu O; Kobayashi M; Shiraishi H; Fujii R; Izumi K
    Jpn J Antibiot; 1986 Jul; 39(7):1715-32. PubMed ID: 3464775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect and tolerance of daily 2 X 1 g imipenem/cilastatin in general surgery].
    Wenzel M; Loch H
    Infection; 1986; 14 Suppl 2():S148-53. PubMed ID: 3531026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of imipenem/cilastatin sodium in the pediatric field].
    Hirosawa H; Hoshina H; Morikawa Y; Ichihashi H
    Jpn J Antibiot; 1986 Jul; 39(7):1733-44. PubMed ID: 3464776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of skin and soft tissue infections with imipenem/cilastatin.
    Fass RJ; Freimer EH; McCloskey RV
    Am J Med; 1985 Jun; 78(6A):110-2. PubMed ID: 3890532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
    Engervall PA; Stiernstedt GT; Günther GC; Björkholm MJ
    J Chemother; 1992 Apr; 4(2):99-106. PubMed ID: 1629753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections.
    Diaz-Mitoma F; Harding GK; Louie TJ; Thomson M; James M; Ronald AR
    Rev Infect Dis; 1985; 7 Suppl 3():S452-7. PubMed ID: 3901207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical studies on imipenem/cilastatin sodium in pediatric field].
    Nagata K; Yokoyama M; Ohnishi A; Izumi Y
    Jpn J Antibiot; 1986 Jul; 39(7):1708-14. PubMed ID: 3464774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.